Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Kirin Holdings Co Ltd    2503   JP3258000003

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Kirin Holdings Co., Ltd. is engaged in the manufacture and sale of beverages and pharmaceutical products.It operates through the following segments: Domestic Alcohol, Domestic Beverages, Foreign Liquor and Beverages, Pharmaceuticals and Biochemicals, and Others.The Domestic Alcohol segment includes... 
Sector
Brewers
Calendar
10/30Earnings Release
Surperformance© rating of Kirin Holdings Co Ltd
Trading Rating : Investor Rating :
More about the company
Chart KIRIN HOLDINGS CO LTD
Duration : Period :
Kirin Holdings Co Ltd Technical Analysis Chart | 2503 | JP3258000003 | 4-Traders
Full-screen chart
Financials ( JPY)
Sales 2014 2 246 015 M
EBIT 2014 126 766 M
Net income 2014 49 164 M
Debt 2014 673 469 M
Yield 2014 2,62%
Sales 2015 2 268 080 M
EBIT 2015 140 373 M
Net income 2015 61 326 M
Debt 2015 624 065 M
Yield 2015 2,84%
PER 2014 27,49
PER 2015 22,12
EV / Sales 2014 0,93x
EV / Sales 2015 0,89x
Capitalization 1 405 523 M
More Financials
Latest news on KIRIN HOLDINGS CO LTD
2d ago Approval for Sustained-Duration G-CSF Product G-Lasta in Japan
6d ago KIRIN : Mercians' mission to preserve peace on island that is divided ; UN ROLE:..
09/23 KIRIN : 180 Mercians join warfare training ; ARMY
09/15 ULTRAGENYX PHARMACEUTICAL : Announces Positive Results From a Long-Term Phase 1/..
09/01 Kyowa Hakko Kirin Announces Commencement of Phase 2b Clinical Study of KHK758..
08/07 NOVO : Prostrakan deal completed
08/05 KIRIN : Mercians off on UN duty to patrol zone that divides Cyprus
07/29 KYOWA HAKKO KIRIN : KIRIN -Announcement of Start of Phase 1 Joint Japanese-Korea..
07/28 KIRIN : Notice Concerning Sale of Shares Held by Untraceable Shareholders
07/12 KIRIN : ProStrakan swoops on rival to hasten growth in Europe
07/08 KYOWA KIRIN -Topical Combination Drug Dovobet Ointment Approved to Treat Psor..
07/03 KYOWA HAKKO KIRIN : Future Development Direction for Bardoxolone Methyl (RTA 402..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF